Berita/Reuters/Curevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechCurevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechRefinitivWaktu baca kurang dari 1 menitCVACGSKPFEBNTXCurevac CVAC said on Thursday that the company and GSK GSK have entered an agreement to resolve patent dispute with Pfizer PFE and BioNTech BNTX over mRNA-based COVID-19 vaccines. EropaLaporan keuanganReutersSaham ASSaham InggrisSaham Jerman© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.htmlPerlihatkan lebih banyakMasuk atau buat akun gratis selamanya untuk membaca berita iniAyo jalan
